Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)

This study has been completed.
Sponsor:
Information provided by:
Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00328224
First received: May 18, 2006
Last updated: October 31, 2007
Last verified: May 2006
  Purpose

To evaluate the dental status of children using ritalin and suffering from ADHA in comparison to healthy children.


Condition
Attention Deficit Disorder With Hyperactivity
Dental Caries
Dental Occlusion, Traumatic

Study Type: Observational
Study Design: Observational Model: Case Control
Official Title: Oral Status and Prevalence of Dental Trauma in Children Treated With Ritalin Due to Attention-Deficit Hyperactivity Disorder (ADHD)

Resource links provided by NLM:


Further study details as provided by Hadassah Medical Organization:

Enrollment: 50
Study Start Date: May 2006
Study Completion Date: October 2007
Detailed Description:

In this trial oral and dental status of 30 children (ages 5-12) who suffer from ADHD and treated with ritalin will be evaluated. Parameters that will be checked are the following: DMFT - decay, missing, filling teeth for dental status, GI - gingival index, PI - plaque index for periodontal status. OJ - over jet and OB - over bite for inter-maxillary relations and susceptibility for dental trauma. In addition these parameters will be collected for 30 age and sex match healthy children.

  Eligibility

Ages Eligible for Study:   5 Years to 12 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Probability Sample
Study Population

healthy children children with adhd treated with ritalin

Criteria

Inclusion Criteria:

  • children ages 5-12 years healthy children children taking ritalin who suffer from ADHD

Exclusion Criteria:

  • all others
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00328224

Locations
Israel
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, Israel, 91120
Sponsors and Collaborators
Hadassah Medical Organization
Investigators
Principal Investigator: Diana Ram, DMD Hadassah Medical Organization
Study Director: Meir Redlich, DMD,PhD Hadassah Medical Organization
Study Director: Hadas Katz-Sagi, DMD Hadassah Medical Organization
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00328224     History of Changes
Other Study ID Numbers: 230606-HMO-CTIL
Study First Received: May 18, 2006
Last Updated: October 31, 2007
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Keywords provided by Hadassah Medical Organization:
ritalin
ADHA
dental status
periodontal status
Attention-Deficit Hyperactivity Disorder
Dental trauma

Additional relevant MeSH terms:
Dental Caries
Dental Occlusion, Traumatic
Attention Deficit Disorder with Hyperactivity
Hyperkinesis
Tooth Demineralization
Tooth Diseases
Stomatognathic Diseases
Malocclusion
Attention Deficit and Disruptive Behavior Disorders
Mental Disorders Diagnosed in Childhood
Mental Disorders
Dyskinesias
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms
Methylphenidate
Dopamine Uptake Inhibitors
Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Neurotransmitter Uptake Inhibitors
Physiological Effects of Drugs
Central Nervous System Stimulants
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on July 22, 2014